Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib

Author(s):
Verboom, M.C.; Kloth, J.S.L.; Swen, J.J.; Straaten, T. van der; Bovee, J.V.M.G. (0000-0003-1155-0481); Sleijfer, S.; Reyners, A.K.L.; Mathijssen, R.H.J.; Guchelaar, H.J. (0000-0002-7085-1383); Steeghs, N.; Gelderblom, H.
Published
2017
Publication type
Article / Letter to editor
GISTImatinibSNPsPharmacogenetic pathway analysisVEGFSurvival
Date issued
2017-11-30
Language
English
Is part of
European Journal of Cancer (2017), Vol. 86, p. 226-232
hdl
1887/116043
doi
10.1016/j.ejca.2017.09.025